Search

everythinglearnresearchcommunity

for

Search:↓

People with weakened immune systems, like those with SLE, are at higher risk for TB.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Dissecting cellulitis and folliculitis keloidalis cause intense inflammation without bacterial infection.

TGF-β1 and TNF-α contribute to lung damage after radiation.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

Renal histology is crucial for diagnosing simultaneous SLE and IgG4RD.

Birt–Hogg–Dubé Syndrome requires genetic testing for accurate diagnosis due to its similarities with tuberous sclerosis.

Early diagnosis and aggressive treatment of lupus nephritis can prevent kidney damage and improve outcomes.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

A 62-year-old man with diabetes and kidney disease had itchy skin lesions diagnosed as perforating folliculitis, treated with medication and skin care.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

Frontal fibrosing alopecia on limbs shows permanent inflammatory hair loss, not typical scarring.

New scientific advancements offer hope for better treatments for skin fibrosis.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

TAF can be identified by excessive skin thickening and clogged hair follicles, helping distinguish it from similar skin conditions.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Tofacitinib is a promising treatment for children with rheumatic diseases.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Rifampicin effectively treated tufted hair folliculitis with no relapse after one year.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.